Botulinum Toxin Type A Attenuates Activation of Glial Cells in Rat Medullary Dorsal Horn with CFA-induced Inflammatory Pain

키워드

참고문헌 (56)

1. Ahnert-Hilger G, "Molecular aspects of tetanus and botulinum neurotoxin poisoning", Prog Neurobiol, 46, pp.83~96 (1995)
2. Traba López A, "Botulinum toxin in motor disorders : practical considerations with emphasis on interventional neurophysiology", Neurophysiol Clin, 31, pp.220~229 (2001)
3. Mense S., "Neurobiological basis for the use of botulinum toxin in pain therapy", J Neurol, 251, pp.I1~I7 (2004)
4. Rollnik JD, "Treatment of tension-type headache with botulinum toxin type A : a double-blind, placebo-controlled study", Headache, 40, pp.300~305 (2000)
5. Foster L, "Botulinum toxin A and chronic low back pain : a randomized, double-blind study", Neurology, 56, pp.1290~1293 (2001)
6. Sheean G, "Botulinum toxin for the treatment of musculoskeletal pain and spasm", Curr Pain Headache Rep, 6, pp.460~469 (2002)
7. Silberstein S, "For the BOTOX Migraine Clinical Research Group", Headache, 40, pp.445~450 (2000)
8. Smuts JA, "Mechanism of action of botulinum toxin type A in migraine prevention : a pilot study", Headache, 44, pp.801~805 (2004)
9. Göbel H, "Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes", Pain, 91, pp.195~199 (2001)
10. Bach-Rojecky L, "Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain", Croat Med J, 46, pp.201~208 (2005)
11. Cui M, "Subcutaneous administration of botulinum toxin A reduces formalininduced pain", Pain, 107, pp.125~133 (2004)
12. Welch MJ, "Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins", Toxicon, 38, pp.245~258 (2000)
13. Won-Ho Lee, "Intrathecal Administration of Botulinum Neurotoxin Type A Attenuates Formalin-Induced Nociceptive Responses in Mice", Anesthesia & Analgesia, 112(1), pp.228~235 (2011), Ovid Technologies (Wolters Kluwer Health)[DOI]
14. Luvisetto S, "Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice", Brain Res, 1082, pp.124~131 (2006)
15. Lidija Bach-Rojecky, "Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection", European Journal of Pharmacology, 633(1-3), pp.10~14 (2010), Elsevier BV[DOI]
16. Lidija Bach-Rojecky, "Central origin of the antinociceptive action of botulinum toxin type A", Pharmacology Biochemistry and Behavior, 94(2), pp.234~238 (2009), Elsevier BV[DOI]
17. Geun Woo Lee, "Peripheral and central administration of botulinium toxin type A attenuated orofacial pain in rats", 석사, Dept. of Dentistry, Major in Oral Biology, pp.2014
18. Y. Kitamura, "Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction", Neuroscience, 159(4), pp.1422~1429 (2009), Elsevier BV[DOI]
19. Durham PL, "Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A : implications for migraine therapy", Headache, 44, pp.35~42 (2004)
20. Meng J, "Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential", J Cell Sci, 120, pp.2864~2874 (2007)
21. Gazerani P, "The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization", Pain, 122, pp.315~325 (2006)
22. Borodic GE, "The use of botulinum toxin for the treatment of chronic facial pain", J Pain, 3, pp.21~27 (2002)
23. Guo W, "Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain", J Neurosci, 27, pp.6006~6018 (2007)
24. Ren K, "Interactions between the immune and nervous systems in pain", Nat Med, 16, pp.1267~1276 (2010)
25. Xie YF, "Involvement of glia in central sensitization in trigeminal subnucleus caudalis(medullary dorsal horn)", Brain Behav Immun, 21, pp.634~641 (2007)
26. Ahn DK, "Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats", Neurosci Lett, 243, pp.105~108 (1998)
27. Ahn DK, "Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats", Pain, 117, pp.204~213 (2005)
28. Wang XM, "Effect of antisense knock-down of alpha(2a)-and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat", Pain, 98, pp.27~35 (2002)
29. Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
30. Min-Kyoung Park, "Participation of Peripheral P2X Receptors in Orofacial Inflammatory Nociception in Rats", International Journal of Oral Biology, 36(3), pp.143~148 (2011), 대한구강생물학회
31. S. R. Han, "Early Dexamethasone Relieves Trigeminal Neuropathic Pain", Journal of Dental Research, 89(9), pp.915~920 (2010), SAGE Publications[DOI]
32. Park CK, "Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system", Pain, 144, pp.84~94 (2009)
33. Rizo J, "Mechanics of membrane fusion", Nat Struct Biol, 5, pp.839~842 (1998)
34. Kim HJ, "Antinociceptive effects of transcytosed botulinum neurotoxin type A on trigeminal nociception in rats" (2015), KJPP
35. Kreutzberg GW, "Microglia : a sensor for pathological events in the CNS", Trends Neurosci, 19, pp.312~318 (1996)
36. Kazuhide Inoue, "Purinergic systems, neuropathic pain and the role of microglia", Experimental Neurology, 234(2), pp.293~301 (2012), Elsevier BV[DOI]
37. Makoto Tsuda, "Purinergic system, microglia and neuropathic pain", Current Opinion in Pharmacology, 12(1), pp.74~79 (2012), Elsevier BV[DOI]
38. Garrison CJ, "Staining of glial fibrillary acidic protein(GFAP)in lumbar spinal cord increases following a sciatic nerve constriction injury", Brain Res, 565, pp.1~7 (1991)
39. Didier M, "Differential immunocytochemical staining for glial fibrillary acidic(GFA)protein, S-100 protein and glutamine synthetase in the rat subcommissural organ, nonspecialized ventricular ependyma and adjacent neuropil", Cell Tissue Res, 245, pp.343~351 (1986)
40. Sweitzer SM, "Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat", Brain Res, 829, pp.209~221 (1999)
41. Colburn RW, "The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior", Exp Neurol, 157, pp.289~304 (1999)
42. Zhuang ZY, "A peptide c-Jun N-terminal kinase(JNK)inhibitor blocks mechanical allodynia after spinal nerve ligation : respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance", J Neurosci, 26, pp.3551~3560 (2006)
43. W. Dieb, "Astrocytes are Involved in Trigeminal Dynamic Mechanical Allodynia: Potential Role of D-serine", Journal of Dental Research, 92(9), pp.808~813 (2013), SAGE Publications[DOI]
44. SeungHwan Lee, "Distinctive response of CNS glial cells in oro-facial pain associated with injury, infection and inflammation", Molecular Pain, 6(1), pp.79~ (2010), SAGE Publications[DOI]
45. Lindia JA, "Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain", J Pain, 6, pp.434~438 (2005)
46. Raghavendra V, "Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS", Eur J Neurosci, 20, pp.467~473 (2004)
47. Hua Y, "Three SNARE complexes cooperate to mediate membrane fusion", Proc Natl Acad Sci U S A, 98, pp.8065~8070 (2001)
48. Südhof TC, "The synaptic vesicle cycle revisited", Neuron, 28, pp.317~320 (2000)
49. Keller JE, "The role of the synaptic protein snap-25in the potency of botulinum neurotoxin type A", J Biol Chem, 276, pp.13476~13482 (2001)
50. Schiavo G, "Neurotoxins affecting neuroexocytosis", Physiol Rev, 80, pp.717~766 (2000)
51. I. Matak, "Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A", Neuroscience, 186, pp.201~207 (2011), Elsevier BV[DOI]
52. S. Marinelli, "Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models", Neuroscience, 171(1), pp.316~328 (2010), Elsevier BV[DOI]
53. DeLeo JA, "The role of neuroinflammation and neuroimmune activation in persistent pain", Pain, 90, pp.1~6 (2001)
54. Marchand F, "Role of the immune system in chronic pain", Nat Rev Neurosci, 6, pp.521~532 (2005)
55. Watkins LR, "Glial activation : a driving force for pathological pain", Trends Neurosci, 24, pp.450~455 (2001)
56. Wieseler-Frank J, "Glial activation and pathological pain", Neurochem Int, 45, pp.389~395 (2004)

관련 논문AI추천